General Information：
Human Long Arg3 Insulin-like Growth Factor-I(Long-R3-IGF-I) is an 83 amino acid analog of human IGF-I comprising the complete human IGF-I sequence with the substitution of an Arg for the Glu at position 3 (hence R3), and a 13 amino acid extension peptide at the N-terminus. Scientists have engineered this analog with the express purpose of increasing biological activity.
Human Long-R3-IGF-I is significantly more potent than human IGF-I in vitro. The enhanced potency is due to the markedly decreased binding of human Long-R3-IGF-I to IGF binding proteins which normally inhibit the biological actions of IGFs.
Expression Host: E. coli
Molecular Mass:
The recombinant human Long-R3-IGF-I has a calculated molecular mass of 9111Da.
Formulation:
Lyophilized from sterile PBS , pH 7.2, and 5 % mannitol are added as protectants before lyophilization.
Quality Control
Purity: > 95 % as as determined by the following methods:
(a) RP-HPLC analysis
(b) SDS-PAGE silver-stained gel analysis
Bio-activity:
The ED50 of recombinant human Long R3 IGF-I, calculated by the dose-dependant proliferation of murine BALBC 3T3 cells, is less
than 1.0ng/ml, corresponding to a specific activity of 1.0×106IU/mg.
Endotoxin:
﹤ 1.0 EU/mg as determined by the LAL method. Product specification：
100ug/vial；500ug/vial；1mg/vial.
Store at：
2-8oC for two years，Avoid repeated freeze and thaw.
關(guān)鍵字： igf;細(xì)胞因子;胰島素樣生長(zhǎng)因子1;長(zhǎng)鏈胰島素樣生長(zhǎng)因子1;
杭州普羅醫(yī)藥科技有限公司是一家集基因工程重組蛋白質(zhì)研發(fā)，生產(chǎn)及銷(xiāo)售于一體的高新技術(shù)企業(yè)。擁有標(biāo)準(zhǔn)化的實(shí)驗(yàn)室，生產(chǎn)車(chē)間，檢驗(yàn)室及倉(cāng)庫(kù)，面積1500平方。公司能夠?yàn)榭蛻?hù)提供從克級(jí)到公斤級(jí)的重組蛋白以及基因工程酶的生產(chǎn)和服務(wù)。
公司擁有一支由專(zhuān)業(yè)的博士及碩士組成的技術(shù)團(tuán)隊(duì)，能夠?yàn)榭蛻?hù)提供一整套的技術(shù)解決方案；公司的質(zhì)量控制部門(mén)是一支受過(guò)嚴(yán)格GMP培訓(xùn)及ISO培訓(xùn)的質(zhì)量技術(shù)人員，能夠通過(guò)專(zhuān)業(yè)技術(shù)檢測(cè)對(duì)對(duì)公司產(chǎn)品進(jìn)行嚴(yán)格的質(zhì)量控制。